Fig. 6
Kaplan–Meier analysis for long-term survival. In the 30 cases studied, transplant-free survival from the administration of add-on tolvaptan by Kaplan–Meier analysis is compared. Patients are stratified according to (a) bioimpedance-defined intracellular water (ICWBIA) decreases or increases after add-on tolvaptan; eight vs ten events; b response to tolvaptan; eight vs ten events; c Model for End-stage Liver Disease (MELD) score at 18; fifteen vs three events; d Child-Pugh-Turcotte (CPT) grade B or C; eight vs ten events; e MELDNa score at 20; nine vs nine events. P-values and hazard ratio from log-rank tests are shown. *P < 0.05